|
Ms. Brege is currently Executive Vice President and Chief Business Officer of Onyx Pharmaceuticals, Inc., where she oversees Finance, including Information Technology; Business Development; Legal; Human Resources, including Facilities; Compliance and Investor Relations. Onyx Pharmaceuticals is focused on developing and commercializing innovative cancer treatments.
Prior to joining Onyx Pharmaceuticals, Ms. Brege was a General Partner at Red Rock Management, a venture capital firm specializing in early stage financing for technology companies. Prior to her work at Red Rock Management, she was the Senior Vice President and Chief Financial Officer at COR Therapeutics, a biotechnology company that specialized in drug therapies for cardiovascular disease. While at COR, Ms. Brege was instrumental in helping the company grow from a research and development start-up to an operations-based enterprise with a commercialized product. Before joining COR, Ms. Brege was Vice President and Chief Financial Officer at Flextronics, a multi-billion dollar electronics manufacturer. She was also Vice President and Treasurer of The Cooper Companies, a Fortune 500 diversified company with operations worldwide.
Ms. Brege earned her undergraduate degree from Ohio University and has an MBA from the University of Chicago. | 